장질환 검사 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 질환 유형별, 최종사용자별, 지역별, 경쟁별(2020-2030년)
Enteric Disease Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Disease Type, End User, by region, and Competition, 2020-2030F
상품코드:1881639
리서치사:TechSci Research
발행일:2025년 11월
페이지 정보:영문 182 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 장질환 검사 시장은 2024년에 41억 2,000만 달러로 평가되었으며, 2030년까지 CAGR 4.87%로 성장하여 54억 8,000만 달러에 달할 것으로 예측됩니다.
장질환 검사란 주로 세균, 바이러스, 기생충에 의해 발생하는 소화관에 영향을 미치는 감염을 확인하기 위한 진단 절차를 말합니다. 이 검사 세계 시장은 주로 전 세계 장 감염증의 확산 증가와 진단 조사 방법의 지속적인 발전에 의해 주도되고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
41억 2,000만 달러
시장 규모 : 2030년
54억 8,000만 달러
CAGR : 2025-2030년
4.87%
가장 빠르게 성장하는 부문
세균성 장질환 부문
최대 시장
북미
주요 시장 촉진요인
전 세계적으로 장내 감염에 대한 부담이 증가함에 따라 진단 검사 솔루션에 대한 수요가 크게 증가하고 있습니다. 불충분한 위생 환경과 오염된 음식물 및 식수로 인해 악화되는 경우가 많은 이러한 전염병의 광범위한 확산은 발생을 관리하고 추가 확산을 방지하기 위해 강력한 감시 체계와 신속한 식별이 필요합니다.
주요 시장 과제
첨단 진단 기술 개발 및 도입에 따른 비용 상승은 세계 장질환 검사 시장의 성장에 큰 장벽으로 작용하고 있습니다. 이러한 고비용은 특히 자원이 부족한 의료 시스템에서 고급 검사 플랫폼의 도입을 직접적으로 제한하고 있습니다.
주요 시장 동향
진단 워크플로우에 디지털 헬스 통합은 환자 데이터 수집, 공유 및 관리 방법을 효율화하는 중요한 트렌드입니다. 이러한 발전으로 진단 플랫폼이 전자건강기록 및 원격의료 시스템과 연계되어 효율성과 접근성이 향상되고 있습니다.
The Global Enteric Disease Testing Market, valued at USD 4.12 Billion in 2024, is projected to experience a CAGR of 4.87% to reach USD 5.48 Billion by 2030. Enteric disease testing encompasses diagnostic procedures designed to identify infections affecting the gastrointestinal tract, typically caused by bacteria, viruses, or parasites. The global market for these tests is primarily driven by the escalating prevalence of enteric infections worldwide and continuous advancements in diagnostic methodologies.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 4.12 Billion
Market Size 2030
USD 5.48 Billion
CAGR 2025-2030
4.87%
Fastest Growing Segment
Bacterial Enteric Diseases Segment
Largest Market
North America
Key Market Drivers
The increasing global burden of enteric infections significantly fuels the demand for diagnostic testing solutions. The widespread prevalence of these infections, often exacerbated by inadequate sanitation and contaminated food or water, necessitates robust surveillance and rapid identification to manage outbreaks and prevent further spread. For instance, according to the CDC's Foodborne Diseases Active Surveillance Network (FoodNet) 2023 Preliminary Data, the incidence of infections from pathogens such as Campylobacter, Cyclospora, Shiga toxin-producing E. coli (STEC), Vibrio, and Yersinia increased in 2023 compared with the 2016-2018 baseline, underscoring a persistent and growing threat. Concurrently, technological innovations in diagnostic testing are transforming the market by offering more accurate, faster, and accessible detection methods, including molecular diagnostics, immunoassays, and point-of-care platforms.
Key Market Challenges
The elevated costs associated with developing and implementing advanced diagnostic technologies present a significant impediment to the growth of the Global Enteric Disease Testing Market. These high expenditures directly limit the adoption of sophisticated testing platforms, particularly within healthcare systems operating in resource-constrained environments. Such financial barriers restrict access to accurate and rapid diagnostics, leading to delayed diagnoses and treatment for enteric infections. This directly reduces the market penetration of advanced solutions, as facilities are often compelled to prioritize less expensive, albeit potentially less effective, testing methods.
Key Market Trends
Digital health integration within diagnostic workflows is a pivotal trend, streamlining how patient data is collected, shared, and managed. This development connects diagnostic platforms with electronic health records and telehealth systems, enhancing efficiency and accessibility. According to the CDC, in April 2024, over 36,000 healthcare facilities could send electronic case reports, an increase from over 25,000 in early 2023, facilitating quicker public health responses to infectious disease threats. This interconnectivity supports comprehensive patient management and rapid epidemiological surveillance.
Key Market Players
Abbott Laboratories Ltd.
Becton Dickinson & Co.
Biomerica Inc.
BioMerieux SA
Bio-Rad Laboratories, Inc.
Cepheid
Coris BioConcept
DiaSorin S.p.A.
Meridian Bioscience Inc.
Quest Diagnostics Incorporated
Report Scope:
In this report, the Global Enteric Disease Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Enteric Disease Testing Market, By Disease Type:
Bacterial Enteric Diseases
Viral Enteric Diseases
Parasitic Enteric Diseases
Rotavirus
Norovirus
Enteric Disease Testing Market, By End-User:
Hospitals & Clinics
Diagnostic Centers
Others
Enteric Disease Testing Market, By Region:
North America
Europe
Asia-Pacific
Soth America
MEA
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Enteric Disease Testing Market.
Available Customizations:
Global Enteric Disease Testing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Enteric Disease Testing Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Disease Type (Bacterial Enteric Diseases, Viral Enteric Diseases, Parasitic Enteric Diseases, Rotavirus, Norovirus)
5.2.2. By End-User (Hospitals & Clinics, Diagnostic Centers, Others)
5.2.3. By Region
5.2.4. By Company (2024)
5.3. Market Map
6. North America Enteric Disease Testing Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Disease Type
6.2.2. By End-User
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Enteric Disease Testing Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Disease Type
6.3.1.2.2. By End-User
6.3.2. Canada Enteric Disease Testing Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Disease Type
6.3.2.2.2. By End-User
6.3.3. Mexico Enteric Disease Testing Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Disease Type
6.3.3.2.2. By End-User
7. Europe Enteric Disease Testing Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Disease Type
7.2.2. By End-User
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Enteric Disease Testing Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Disease Type
7.3.1.2.2. By End-User
7.3.2. France Enteric Disease Testing Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Disease Type
7.3.2.2.2. By End-User
7.3.3. United Kingdom Enteric Disease Testing Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Disease Type
7.3.3.2.2. By End-User
7.3.4. Italy Enteric Disease Testing Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Disease Type
7.3.4.2.2. By End-User
7.3.5. Spain Enteric Disease Testing Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Disease Type
7.3.5.2.2. By End-User
8. Asia Pacific Enteric Disease Testing Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Disease Type
8.2.2. By End-User
8.2.3. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Enteric Disease Testing Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Disease Type
8.3.1.2.2. By End-User
8.3.2. India Enteric Disease Testing Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Disease Type
8.3.2.2.2. By End-User
8.3.3. Japan Enteric Disease Testing Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Disease Type
8.3.3.2.2. By End-User
8.3.4. South Korea Enteric Disease Testing Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Disease Type
8.3.4.2.2. By End-User
8.3.5. Australia Enteric Disease Testing Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Disease Type
8.3.5.2.2. By End-User
9. Middle East & Africa Enteric Disease Testing Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Disease Type
9.2.2. By End-User
9.2.3. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Enteric Disease Testing Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Disease Type
9.3.1.2.2. By End-User
9.3.2. UAE Enteric Disease Testing Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Disease Type
9.3.2.2.2. By End-User
9.3.3. South Africa Enteric Disease Testing Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Disease Type
9.3.3.2.2. By End-User
10. South America Enteric Disease Testing Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Disease Type
10.2.2. By End-User
10.2.3. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Enteric Disease Testing Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Disease Type
10.3.1.2.2. By End-User
10.3.2. Colombia Enteric Disease Testing Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Disease Type
10.3.2.2.2. By End-User
10.3.3. Argentina Enteric Disease Testing Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Disease Type
10.3.3.2.2. By End-User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Enteric Disease Testing Market: SWOT Analysis
